Apmis Journal Citation Rate 2026
0903-4641
eISSN 1600-0463
Wiley
GB
Q2 Quartile Verified Publisher
About Apmis
Apmis (A) is a peer-reviewed academic journal covering Antibiotic Resistance in Bacteria and Antimicrobial Resistance in Staphylococcus, published by Wiley in GB, catalogued under ISSN 0903-4641 (e-ISSN 1600-0463). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.44 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4120 USD). OpenAlex records 6,604 works and 129,822 citations, with an h-index of 123.
Apmis Citation Rate 2026 — In Context
Apmis has a 2025 2-Year Citation Rate (OpenAlex) of 1.44, placing it in the Q2 quartile within the Antibiotic Resistance in Bacteria research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Apmis operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Apmis should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Apmis against similar journals in the field, use our journal comparison tool.
Submission Tips for Apmis
- Budget $4120 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Apmis Compares
Compared against 145 journals in the same research areas.
| ISSN (Print) | 0903-4641 |
|---|---|
| ISSN (Online) | 1600-0463 |
| Publisher | Wiley |
| Country | United Kingdom |
| APC / Cost | $4120 USD |
In-depth profile & metrics
Apmis is published by Wiley and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4120.
In our subject taxonomy, Apmis is classified under Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing and Diverse Scientific and Economic Studies.
Apmis is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.443.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Apmis
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.443 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Apmis against similar publications in its field:
Related Journals in Your Field
-
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Elsevier IF 64.50
-
American Political Science Review Cambridge University Press IF 56.90
-
Chemical Society Reviews The Royal Society of Chemistry IF 31.04
-
Advanced Drug Delivery Reviews Elsevier BV IF 12.22
-
Pharmacology & Therapeutics Elsevier BV IF 10.38
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S135377718
Get weekly updates for Antibiotic Resistance in Bacteria journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.